Management of Incidentally Discovered Pancreatic Cysts
NCT00550108 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2008-06-26
Summary
The purpose of this study is to determine the natural history of pancreatic cysts and to determine if these cysts can be effectively treated with a less invasive therapy (ethanol injection vs periodic imaging) rather than surgical resection
Conditions
- Pancreatic Cyst
Interventions
- OTHER
-
Ethanol lavage
Ethanol lavage of pancreatic cysts.
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Cristina R Ferrone, MD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes
NCT03258853 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions
NCT02261896 ·Status: COMPLETED ·Phase: PHASE4
-
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
NCT00449878 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
NCT02955888 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis
NCT00006063 ·Status: COMPLETED ·Phase: NA
-
IGF-1 Therapy in Patients With Cystic Fibrosis
NCT00566241 ·Status: TERMINATED ·Phase: PHASE1
-
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes
NCT05385211 ·Status: COMPLETED
-
Bionic Pancreas in CFRD
NCT06449677 ·Status: RECRUITING ·Phase: PHASE3
-
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
NCT02137382 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del
NCT02653027 ·Status: WITHDRAWN ·Phase: NA
-
Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
NCT00004806 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Diabetes in Adults With Cystic Fibrosis (CF)
NCT03644199 ·Status: WITHDRAWN ·Phase: NA
-
Genetics of Insulin and Incretins in Cystic Fibrosis
NCT01852448 ·Status: RECRUITING
-
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
NCT00510484 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation
NCT05581056 ·Status: COMPLETED
-
Neuromuscular Characterisation in Late Adolescent and Adult Cystinosis Patients
NCT05545774 ·Status: COMPLETED
-
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
NCT02003079 ·Status: COMPLETED
-
Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
NCT00537602 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
NCT00513682 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)
NCT05526027 ·Status: UNKNOWN ·Phase: NA
-
SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis
NCT02279498 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
NCT00880100 ·Status: COMPLETED ·Phase: PHASE3
-
Exocrine Pancreatic Function Testing in Cystic Fibrosis
NCT01446861 ·Status: UNKNOWN
-
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
NCT01858519 ·Status: COMPLETED
-
A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis
NCT04519853 ·Status: COMPLETED ·Phase: NA